Tandem™ HF rapidly solves the therapeutic cell retention problem by binding cells, relieving anoikis and when delivered into the heart, anchoring cells in the damaged tissue. Furthermore, Tandem™ HF dampens down the immune system reducing cell loss due to immune rejection.
First of its kind injectable, human heart cell-derived biomatrix
Enables retention, distribution of therapeutic cells
Therapeutic cells readily bind and dissociate with biomatrix